Henan Lingrui Pharmaceutical Co., Ltd.

XSSC:600285 Stock Report

Market Cap: CN¥11.7b

Henan Lingrui Pharmaceutical Future Growth

Future criteria checks 2/6

Henan Lingrui Pharmaceutical is forecast to grow earnings and revenue by 16.1% and 12.5% per annum respectively. EPS is expected to grow by 15.7% per annum. Return on equity is forecast to be 26.9% in 3 years.

Key information

16.1%

Earnings growth rate

15.7%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate12.5%
Future return on equity26.9%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600285 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,7209598589543
12/31/20254,1948207398183
12/31/20243,7236966226543
9/30/20243,564676611655N/A
6/30/20243,517664682711N/A
3/31/20243,432614756777N/A
12/31/20233,311568792813N/A
9/30/20233,232526847865N/A
6/30/20233,200512904924N/A
3/31/20233,108479805830N/A
12/31/20223,002465808835N/A
9/30/20222,917440654696N/A
6/30/20222,841412574622N/A
3/31/20222,786396637707N/A
12/31/20212,694362769846N/A
9/30/20212,635383663741N/A
6/30/20212,513368688768N/A
3/31/20212,430346460536N/A
12/31/20202,332325379451N/A
9/30/20202,215302367424N/A
6/30/20202,163288336387N/A
3/31/20202,068270386428N/A
12/31/20192,157294391450N/A
9/30/20192,149292442479N/A
6/30/20192,118280447493N/A
3/31/20192,078270413460N/A
12/31/20182,053243384436N/A
9/30/20182,139240319420N/A
6/30/20182,120230N/A356N/A
3/31/20181,990223N/A201N/A
12/31/20171,849217N/A106N/A
9/30/20171,697198N/A18N/A
6/30/20171,608381N/A52N/A
3/31/20171,513364N/A107N/A
12/31/20161,439346N/A63N/A
9/30/20161,315365N/A113N/A
6/30/20161,225152N/A100N/A
3/31/20161,133141N/A110N/A
12/31/20151,085132N/A225N/A
9/30/20151,006119N/A251N/A
6/30/2015936115N/A203N/A
3/31/201590197N/A173N/A
12/31/201482676N/A124N/A
9/30/201480275N/A130N/A
6/30/201475765N/A129N/A
3/31/201471859N/A130N/A
12/31/2013687105N/A127N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600285's forecast earnings growth (16.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 600285's earnings (16.1% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 600285's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600285's revenue (12.5% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 600285's revenue (12.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600285's Return on Equity is forecast to be high in 3 years time (26.9%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y